Tenri Hospital is an international hospital in Tenri City, Nara Prefecture, Japan. It was founded on April 1, 1966. It was founded as part of the secular mission of Tenrikyo.

During the past decade, Tenri Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tenri Hospital" #1 sponsor was "Chugai Pharmaceutical" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "CSL Behring" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tenri Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Asahi Intech" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Japan Lifeline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Tenri Hospital" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Acute Myeloid Leukemia" (1 trials), "Atrial Fibrillation" (1 trials), "Chronic Respiratory Failure" (1 trials) and "Coronary Occlusion" (1 trials). Many other conditions were trialed in "Tenri Hospital" in a lesser frequency.

Most popular intervention types in "Tenri Hospital" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Bendamustine" (1 trials), "Bosentan" (1 trials) and "Chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tenri Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Tenri Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Tenri Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tenri Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".